Using CRISPR-Cas technology, they eliminate or resensitise multi-resistant strains of E. coli without affecting the gut microbiota
Read moreBlocking specific cellular signaling pathways may be an effective approach to treating this type of cutaneous lymphoma. One of its characteristics is its high genetic and molecular heterogeneity, whic...
Read moreThe study shows that the colitis model induced with 2,4,6-trinitrobenzenesulfonic acid (TNBS) develops hyperplasia of the mesocolic adipose tissue, presenting macroscopic, histological, immunological ...
Read moreSe desarrollará en el Hospital 12 de Octubre y reclutará pacientes con tumores de mama o ginecológicos tratadas con ADCs, anticuerpos fármaco-conjugados
Read moreAuthored by an international team with the significant involvement of researchers from IDIBAPS-Hospital Clínic Barcelona, JAMA Psychiatry has published the first review to synthesise and comprehensiv...
Read moreUn estudio enmarcado dentro del proyecto MONKPOX-ESP22 liderado por el CIBER muestra que las personas que viven con VIH no desarrollaron formas más graves de mpox durante el brote multirregional regi...
Read moreUnderstanding the responsibilities involved in Drug Substance and Drug Product manufacturing is essential for making the right strategic decisions. Many biotech companies approaching clinical phases d...
Read moreSe trata de la videourodinamia, que precisa mucho más el diagnóstico en niños que sufren incontinencia grave o deterioro de los riñones
Read moreA multiomic study describes, for the first time, the accumulation of genetic alterations that dictate the malignancy of a type of thyroid tumour, more prevalent in children and young adults.
Read moreA team of researchers from the University of Extremadura has discovered that the Notch1 signaling pathway regulates two calcium channels, Orai1 and Orai3, differently depending on the breast cancer su...
Read moreThe simultaneous detection of H.pylori antigen and transferrin in stool samples using a rapid test represents a significant advance in non-invasive diagnosis, as it allows both the infection caused by...
Read moreThe REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.
Read more